Overview

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The object of this study is to assess the efficacy and safety of zonisamide as adjunctive therapy in patients with uncontrolled partial epilepsy.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Korea Inc.
Treatments:
Zonisamide